{"id":"https://openalex.org/W4391400007","doi":"https://doi.org/10.3389/fphar.2024.1356013","title":"A retrospective study on the efficacy and safety of Envafolimab, a PD-L1 inhibitor, in the treatment of advanced malignant solid tumors","display_name":"A retrospective study on the efficacy and safety of Envafolimab, a PD-L1 inhibitor, in the treatment of advanced malignant solid tumors","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-31","ids":{"openalex":"https://openalex.org/W4391400007","doi":"https://doi.org/10.3389/fphar.2024.1356013","pmid":"https://pubmed.ncbi.nlm.nih.gov/38357311","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10864544"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2024.1356013","doi":"https://doi.org/10.3389/fphar.2024.1356013","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2024.1356013","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2024.1356013/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4391400007"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2024.1356013/pdf?isPublishedV2=False","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066875591","display_name":"Congjun Zhang","orcid":"https://orcid.org/0009-0000-1005-5812","observed_orcids":["https://orcid.org/0009-0000-1005-5812","https://orcid.org/0009-0002-6415-145X"]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/validation","display_name":"Validation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Congjun Zhang","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100338383","display_name":"Jingjing Li","orcid":"https://orcid.org/0000-0002-4410-2629","observed_orcids":["https://orcid.org/0000-0002-4410-2629"]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Jingjing Li","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021940103","display_name":"Hongyang Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Hongyang Wu","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102748047","display_name":"Wei Huang","orcid":"https://orcid.org/0000-0002-3468-7467","observed_orcids":["https://orcid.org/0000-0002-3468-7467"]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Wei Huang","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073778832","display_name":"Liangshan Da","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Liangshan Da","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030152933","display_name":"Yuanyuan Shen","orcid":"https://orcid.org/0000-0002-3287-5210","observed_orcids":["https://orcid.org/0000-0002-3287-5210"]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Yuanyuan Shen","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026026306","display_name":"Guoping Sun","orcid":"https://orcid.org/0000-0002-4325-900X","observed_orcids":["https://orcid.org/0000-0002-4325-900X"]},"institutions":[{"id":"https://openalex.org/I4210136596","display_name":"First Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/03t1yn780","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210136596"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/validation","display_name":"Validation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Guoping Sun","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China","institution_ids":["https://openalex.org/I4210136596"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026026306"],"corresponding_institution_ids":["https://openalex.org/I4210136596"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":0.8628,"has_fulltext":true,"cited_by_count":6,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.73131491,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"15","issue":null,"first_page":"1356013","last_page":"1356013"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/envafolimab","display_name":"envafolimab","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9639999866485596},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7379999756813049},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9599999785423279},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.8370000123977661},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.800000011920929},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9010000228881836},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6079999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8792057037353516},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8646008968353271},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7753607034683228},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.7272765040397644},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6771986484527588},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6336879134178162},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4284262955188751},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4092159569263458}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2024.1356013","doi":"https://doi.org/10.3389/fphar.2024.1356013","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2024.1356013","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2024.1356013/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10864544","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10864544","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10864544/pdf/fphar-15-1356013.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:38357311","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38357311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:59a32aab4c924dc8861213e5c4aaab29","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/59a32aab4c924dc8861213e5c4aaab29","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 15 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2024.1356013","doi":"https://doi.org/10.3389/fphar.2024.1356013","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2024.1356013","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2024.1356013/pdf?isPublishedV2=False","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9994999766349792,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391400007.pdf","grobid_xml":"https://content.openalex.org/works/W4391400007.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1940241680","https://openalex.org/W2055953960","https://openalex.org/W2104347254","https://openalex.org/W2145857936","https://openalex.org/W2289712604","https://openalex.org/W2572174216","https://openalex.org/W2587048937","https://openalex.org/W2588916311","https://openalex.org/W2592103537","https://openalex.org/W2760942750","https://openalex.org/W2772677509","https://openalex.org/W2911303559","https://openalex.org/W2943606118","https://openalex.org/W2947917218","https://openalex.org/W3156543781","https://openalex.org/W3160750332","https://openalex.org/W3162575990","https://openalex.org/W3173489450","https://openalex.org/W4232349440","https://openalex.org/W4289978183","https://openalex.org/W4296400713","https://openalex.org/W4311585877","https://openalex.org/W4312018381","https://openalex.org/W4321099956","https://openalex.org/W4324145028"],"related_works":["https://openalex.org/W4289978183","https://openalex.org/W4382862333","https://openalex.org/W3160750332","https://openalex.org/W4410803672","https://openalex.org/W3173489450","https://openalex.org/W4387811092","https://openalex.org/W4411388500","https://openalex.org/W4404705698","https://openalex.org/W4393166356","https://openalex.org/W4296400713"],"abstract_inverted_index":{"Envafolimab,":[0],"a":[1,77,86,105,174],"PD-L1":[2],"inhibitor,":[3],"has":[4],"demonstrated":[5],"potential":[6],"in":[7,20,139,149,160,181],"treating":[8],"advanced":[9],"malignant":[10],"solid":[11],"tumors":[12],"(AMST).":[13],"To":[14],"study":[15,24],"its'":[16],"efficacy":[17,73],"and":[18,31,56,74,93,109,125,176,184],"safety":[19],"AMST,":[21,30,180],"our":[22],"retrospective":[23],"recruited":[25],"64":[26],"patients":[27,43,115],"with":[28,33,116,132,143,165,189],"various":[29],"treated":[32],"Envafolimab":[34,52,172],"(400":[35],"mg":[36],"every":[37],"3":[38],"weeks).":[39],"We":[40],"divided":[41],"the":[42],"into":[44],"two":[45],"cohorts:":[46],"Cohort":[47,57,83,102],"1":[48],"(25":[49],"patients)":[50,60],"receiving":[51,61],"as":[53,63],"first-line":[54],"therapy,":[55],"2":[58],"(39":[59],"it":[62],"second-line":[64],"or":[65],"subsequent":[66],"therapy.":[67],"Our":[68],"analysis":[69],"focused":[70],"on":[71],"Envafolimab's":[72],"safety.":[75],"Over":[76],"median":[78],"follow-up":[79],"of":[80,91,99,107,112,141,163],"7.1":[81],"months,":[82],"I":[84],"reported":[85],"Disease":[87],"Control":[88],"Rate":[89],"(DCR)":[90],"72.0%":[92],"an":[94,110],"Objective":[95],"response":[96],"rate":[97],"(ORR)":[98],"12.0%,":[100],"while":[101],"II":[103],"had":[104],"DCR":[106,124],"51.3%":[108],"ORR":[111],"5.1%.":[113],"Notably,":[114],"more":[117],"than":[118,130],"four":[119],"treatment":[120,158,178,191],"cycles":[121],"showed":[122],"higher":[123],"longer":[126],"Progression-Free":[127],"Survival":[128],"(PFS)":[129],"those":[131],"fewer":[133],"cycles.":[134],"Adverse":[135],"events":[136,145,153,168],"were":[137,154],"observed":[138],"68.8%":[140],"patients,":[142,164],"severe":[144],"(CTCAE":[146],"grade":[147],"3/4)":[148],"14.1%.":[150],"Most":[151],"adverse":[152],"mild,":[155],"leading":[156],"to":[157],"discontinuation":[159],"only":[161],"3.1%":[162],"no":[166],"life-threatening":[167],"reported.":[169],"In":[170],"summary,":[171],"is":[173],"safe":[175],"effective":[177],"for":[179],"both":[182],"initial":[183],"later":[185],"therapy":[186],"stages,":[187],"particularly":[188],"extended":[190],"duration,":[192],"meriting":[193],"further":[194],"clinical":[195],"trials.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4391400007","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2024-02-01T00:00:00"}
